Childhood Schizophrenia
Definition and Core Concepts
- Schizophrenia is a severe psychiatric disorder characterized by a constellation of psychotic symptoms, including delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, and negative symptoms.
- Childhood (preadolescent)-onset schizophrenia is exceedingly rare, with an incidence of less than 0.04%, and presents with a 2:1 male-to-female ratio.
- Childhood-onset schizophrenia represents a more severe form of the disorder spectrum, carrying more genetic risk factors, more prominent brain abnormalities, and a higher rate of prepsychotic developmental disorders compared to adult-onset variants.
- The essential diagnostic features of schizophrenia are identical in childhood and adulthood; however, the diagnosis is significantly more difficult to establish in the pediatric population due to developmental overlap.
DSM-5 Diagnostic Criteria
| Criterion | Clinical Description |
|---|---|
| Criterion A (Active-Phase) | Two (or more) of the following present for a significant portion of a 1-month period: 1. Delusions 2. Hallucinations 3. Disorganized speech 4. Grossly disorganized or catatonic behavior 5. Negative symptoms (diminished emotional expression or avolition). At least one must be 1, 2, or 3. |
| Criterion B (Dysfunction) | In childhood or adolescence, there is a failure to achieve the expected level of interpersonal, academic, or occupational functioning. |
| Criterion C (Duration) | Continuous signs of the disturbance persist for at least 6 months, including at least 1 month of active-phase symptoms, and may include prodromal or residual periods. |
| Criterion D & E (Exclusions) | Schizoaffective disorder, depressive/bipolar disorders with psychotic features, and physiologic effects of a substance or medical condition must be ruled out. |
| Criterion F (Comorbidity) | If a history of autism spectrum disorder (ASD) or childhood-onset communication disorder exists, schizophrenia is diagnosed only if prominent delusions or hallucinations are additionally present for at least 1 month. |
Clinical Features Specific to Childhood
- In children, delusions and hallucinations may be less elaborate than in adults, and visual hallucinations may be more commonly experienced.
- Disorganized speech in youth might be incorrectly attributed to an underlying communication disorder or ASD.
- The most frequently reported psychotic symptoms in youth with schizophrenia are auditory hallucinations (82%), delusions (78%), thought disorder (66%), disorganized or bizarre behavior (53%), and negative symptoms (50%).
- Negative symptoms include diminished emotional expression, avolition (decreased drive to perform tasks), alogia (lack of speech), anhedonia, and social withdrawal; these account for a substantial portion of the long-term morbidity.
Phases of Illness
| Phase | Clinical Characteristics |
|---|---|
| Prodrome Phase | Involves functional deterioration over months prior to overt psychosis; symptoms include social withdrawal, idiosyncratic preoccupations, odd behaviors, academic failure, deteriorating self-care, and dysphoria. |
| Acute Phase | Characterized by prominent positive symptoms (hallucinations, delusions) and severe deterioration in functioning; this is the phase in which most patients present for care. |
| Recovery Phase | Active psychosis begins to remit, though negative symptoms and disorganization may persist. |
| Residual Phase | Minimal to no positive symptoms are present, but negative symptoms continue to cause impairment. |
Etiology and Pathophysiology
- Evidence supports a neurodevelopmental and neurodegenerative model with interactions between genetic vulnerabilities and environmental risks.
- Monozygotic twin concordance rates are 40% to 60%, compared to 5% to 15% for dizygotic twins.
- Schizophrenia is a polygenic disorder; while common variants contribute to approximately 30% of the risk, rare copy number variants (large genetic deletions/duplications) carry high odds ratios and are responsible for about 12% of cases with onset before 13 years of age.
- Environmental risk factors include in utero exposure to maternal famine, advanced paternal age, prenatal infections, obstetric complications, marijuana use, and immigration.
- Neuroanatomic abnormalities in affected youth include increased lateral ventricle volumes, reductions in hippocampal, thalamic, and frontal lobe volumes, reduced gray matter volumes, and reduced cortical folding.
- Dysfunctional central nervous system dopamine circuits are hypothesized to play a key role in the pathophysiology.
Comorbidities
- Comorbid rates are strikingly high: 34% have posttraumatic stress disorder, 34% have attention-deficit/hyperactivity disorder and/or disruptive behavior disorders, and 32% have substance abuse/dependence.
- At least 10% to 20% of children with schizophrenia have intellectual delays, alongside impairments in language, communication, and information processing.
- Childhood-onset schizophrenia is strongly linked to ASD, with an estimated 30% to 50% of cases being preceded by an ASD diagnosis.
Differential Diagnosis
- The differential diagnosis is broad because many conditions can mimic psychosis while also increasing the risk for it.
- Medical and neurologic conditions that can cause psychotic symptoms include epilepsy (especially temporal lobe or idiopathic occipital epilepsy), strokes, neoplasms, endocrine disorders, genetic syndromes (e.g., velocardiofacial syndrome), autoimmune encephalitis, and permanent sequelae of toxic exposures.
- Substance-induced psychotic disorders must be excluded; offending agents include cannabis, hallucinogens (LSD, psilocybin), stimulants, amphetamines, corticosteroids, and anticholinergics.
| Red Flags Suggesting Secondary (Medical) Psychosis |
|---|
| Very early age of onset ($\le$13 years) |
| Acute or subacute onset (days to $\le$1 month) |
| Presence of catatonia or dyskinesias |
| Depressed level of consciousness, disorientation, somnolence, or recent memory decline |
| Multimodal hallucinations (visual, auditory, olfactory, gustatory) |
| Intractability despite adequate antipsychotic therapy |
Clinical Evaluation
- All children presenting with psychotic symptoms require a thorough pediatric and neurologic evaluation to rule out nonpsychiatric causes.
- No single neuroimaging or laboratory test establishes the diagnosis; testing is utilized to rule out medical etiologies and establish baseline parameters for medication monitoring.
- Routine laboratory testing includes blood counts, a basic metabolic panel, liver/renal/thyroid function tests, and a toxicology screen.
- Neuroimaging (MRI) and electroencephalography (EEG) are indicated if focal neurologic deficits, developmental regression, seizures, or encephalopathy are suspected.
- Genetic testing is indicated if dysmorphic or syndromic features are present.
Management Principles
- Management requires integrated psychopharmacologic, psychotherapeutic, psychoeducational, and case management services due to the chronic and severely impairing nature of the disorder.
- Psychopharmacology: First-generation and second-generation antipsychotic medications are the cornerstone of treatment for reducing positive psychotic symptoms.
- The FDA-approved second-generation antipsychotics for schizophrenia in patients $\ge$13 years include risperidone, aripiprazole, quetiapine, olanzapine, and lurasidone.
- Paliperidone is FDA-approved for patients $\ge$12 years.
- Clozapine is highly effective for both positive and negative symptoms but is reserved for treatment-resistant cases due to the severe risks of agranulocytosis and seizures.
- All antipsychotics carry risks of sedation, weight gain, and extrapyramidal symptoms, requiring rigorous metabolic and neurologic monitoring.
- Psychosocial and Educational Interventions: Psychoeducation regarding the illness is critical to improve treatment adherence, as over 75% of youth with schizophrenia discontinue their medication within 6 months. Specialized educational programs, school liaisons, and cognitive remediation therapies are essential to address the profound academic and social deficits.
- Electroconvulsive Therapy (ECT): ECT is considered for severely impaired adolescents when antipsychotic medications are either ineffective or cannot be tolerated.